Role of mitochondria in neonatal hypoxic-ischemic encephalopathy

• Weijing Kong ^[1] ; Cheng Lu ^[1]
  1. [1] Beijing Friendship Hospital

     Beijing Friendship Hospital

     China

     
• Localización: Histology and histopathology: cellular and molecular biology, ISSN-e 1699-5848, ISSN 0213-3911, Vol. 39, Nº. 8, 2024, págs. 991-1000
• Idioma: inglés
• Enlaces
  • Texto completo
• Resumen

  • Neonatal hypoxic-ischemic encephalopathy, an important cause of death as well as long-term disability in survivors, is caused by oxygen and glucose deprivation, and limited blood flow. Following hypoxicischemic injury in the neonatal brain, three main biochemical damages (excitotoxicity, oxidative stress, and exacerbated inflammation) are triggered.

    Mitochondria are involved in all three cascades.

    Mitochondria are the nexus of metabolic pathways to offer most of the energy that our body needs. Hypoxicischemic injury affects the characteristics of mitochondria, including dynamics, permeability, and ATP production, which also feed back into the process of neonatal hypoxic-ischemic encephalopathy. Mitochondria can be a cellular hub in inflammation, which is another main response of the injured neonatal brain.

    Some treatments for neonatal hypoxic-ischemic encephalopathy affect the function of mitochondria or target mitochondria, including therapeutic hypothermia and erythropoietin. This review presents the main roles of mitochondria in neonatal hypoxic-ischemic encephalopathy and discusses some potential treatments directed at mitochondria, which may foster the development of new therapeutic strategies for this encephalopathy.